The Biomonitoring Massachusetts Study is being conducted by the Massachusetts Department of Public Health with funding and technical support provided through a Cooperative Agreement with the US Centers for Disease Control and Prevention (CDC).
For more information, please visit the state-based CDC program page.
The goal of the Biomonitoring Massachusetts Study is to augment CDC’s National Biomonitoring Program (NBP) by improving the capacity of MDPH to detect, diagnose, and prevent adverse health outcomes following exposure to harmful levels of toxic chemicals.
Through the Biomonitoring Massachusetts Study, MDPH will:
- Determine levels of PCBs and select metals in a representative sample of adult Massachusetts residents.
- Determine levels of select toxicants in susceptible individuals in communities with a high risk of potential exposure.
- Enhance the capacity and capability to conduct rapid biomonitoring assessment following episodic chemical exposure events or acute chemical emergencies.
The Biomonitoring Massachusetts Study is led by MDPH investigators and a team of highly skilled scientists in both the Analytical Chemistry Division at the State Public Health Laboratory and the Environmental Toxicology Program in the Bureau of Environmental Health.
The levels of chemicals that are measured in study participants will be compared to levels that CDC has measured from a nationwide sample of a similar demographic group (e.g., age, gender, and race/ethnicity). Additional information about the data collected from this nationwide sample may be found in the CDC National Exposure Report.
For more information please contact:
Environmental Toxicology Program|
MDPH Bureau of Environmental Health
Massachusetts Department of Public Health
250 Washington Street, 7th Floor, Boston, MA 02108
Phone: 617-624-5757 | Fax: 617-624-5777 | TTY: 617-624-5286